Global Fertility Clinic Market to Reach USD 45.8 Billion by 2030 at 8.2% CAGR

The global Fertility Clinic market has witnessed robust growth, driven by rising infertility cases, delayed parenthood, and increasing adoption of assisted reproductive technologies (ART). In 2022, the market was valued at USD 28.6 billion and grew to USD 30.9 billion in 2023, reflecting a 8.1% year-over-year increase. Analysts project the market to reach USD 45.8 billion by 2030, with a CAGR of 8.2% from 2024 to 2030.

Historical Market Trends

From 2013 to 2022, the fertility clinic market expanded from USD 14.2 billion to USD 28.6 billion, a CAGR of 7.8%. North America dominated, contributing USD 8.3 billion in 2013 and USD 14.0 billion in 2022, driven by high ART adoption and insurance support. Europe grew from USD 3.8 billion to USD 7.2 billion over the same period. Asia-Pacific revenue increased from USD 1.9 billion in 2013 to USD 5.8 billion in 2022, reflecting a CAGR of 11.2% due to rising infertility awareness and government incentives.

In 2017, global revenue reached USD 21.0 billion, a 7.2% increase from USD 19.6 billion in 2016. Despite COVID-19 disruptions, the market recovered in 2021 to USD 27.3 billion, up 6.5% from 2020, driven by pent-up demand and resumption of elective fertility treatments.

Regional Market Analysis

North America dominated in 2023 with USD 15.1 billion (48.9% of global revenue). The U.S. contributed USD 12.4 billion, while Canada accounted for USD 2.7 billion. Europe generated USD 7.6 billion (24.6%), with Germany, the U.K., and France collectively contributing USD 5.1 billion. Asia-Pacific recorded USD 6.4 billion (20.7%), led by China (USD 2.5 billion), India (USD 1.8 billion), and Japan (USD 1.1 billion). Latin America reached USD 1.3 billion, expanding 8.5% year-over-year, while the Middle East & Africa accounted for USD 0.5 billion.

Service Segmentation

In vitro fertilization (IVF) dominated in 2023, generating USD 17.5 billion (56.6% share), with a CAGR of 8.0% from 2024 to 2030. Intracytoplasmic sperm injection (ICSI) contributed USD 6.1 billion, growing 8.4% annually. Surrogacy services generated USD 3.5 billion, expanding 9.0%, while other ART treatments accounted for USD 3.8 billion, reflecting a 7.7% growth rate.

Patient Demographics

Women aged 30–40 were the largest patient group in 2023, accounting for USD 19.8 billion (64% of revenue), growing at 8.3% CAGR. Women aged 25–30 contributed USD 6.2 billion, expanding 7.6%. Male fertility treatments represented USD 4.9 billion, growing 8.1%. Rising age-related infertility and delayed family planning are primary growth drivers across all age groups.

Key Players and Competitive Landscape

Major fertility clinic chains include CCRM, Shady Grove Fertility, IVI-RMA Global, Bourn Hall Clinic, and CREATE Fertility, collectively holding 36% of global revenue. CCRM generated USD 3.2 billion in 2023, growing 8.2% year-over-year. IVI-RMA Global contributed USD 2.7 billion, a 7.9% increase. Bourn Hall Clinic generated USD 1.5 billion, expanding 8.0%, while CREATE Fertility contributed USD 1.0 billion. Companies focus on expanding clinic networks, adopting advanced ART technologies, and offering personalized care.

Investment and Innovation

Global R&D investment in fertility treatments reached USD 1.45 billion in 2023, a 9.1% increase from 2022. North America contributed USD 640 million, Europe USD 410 million, and Asia-Pacific USD 300 million. Innovation focuses on improving IVF success rates, cryopreservation techniques, and genetic screening. Government funding in ART programs totaled USD 520 million globally in 2023, with USD 240 million allocated in North America and USD 140 million in Asia-Pacific.

Market Drivers and Challenges

Infertility prevalence reached 15% globally in 2023, increasing demand for fertility clinics. The number of ART cycles conducted worldwide rose from 2.2 million in 2017 to 3.6 million in 2023, a CAGR of 8.0%. Delayed parenthood trends in developed countries, coupled with rising awareness in emerging economies, are major growth drivers. Challenges include high treatment costs and regulatory restrictions in certain regions, affecting adoption rates.

Future Market Outlook

The fertility clinic market is projected to reach USD 45.8 billion by 2030. North America is expected to generate USD 22.5 billion, expanding at 7.9% CAGR. Asia-Pacific will reach USD 10.8 billion, growing at 9.2% CAGR, driven by increasing ART adoption and government subsidies. IVF and ICSI will remain dominant services, while surrogacy and donor programs will see fastest growth in emerging regions.

Conclusion

The global fertility clinic market has grown from USD 14.2 billion in 2013 to USD 30.9 billion in 2023, reflecting rising infertility and technological advancements in ART. With growing patient awareness, delayed parenthood, and expansion in Asia-Pacific, the market is projected to reach USD 45.8 billion by 2030. IVF and ICSI will continue to dominate, supported by innovation and government funding across key regions.

Read Full Research Study: Fertility Clinic https://marketintelo.com/report/fertility-clinic-market